Mesa Labs Q1: revenue up 44% but net loss of $1.4M; organic growth slows to 3%

MESA LABORATORIES INC /CO/

2023-Q1 EPS reported -$0.27 revenue$50,453,000

GAAP diluted EPS loss of ($0.27) vs prior-year EPS of $0.38; net loss of ($1.438M) from $1.995M income.
Revenue $50.5M (+44% total, +3% organic); non-GAAP adjusted OI $6.158M (-33%) or $1.17/share.
Clinical Genomics (29% rev) hit by China lockdowns; Sterilization & Disinfection down 2%.
Biopharma Development grew 24%; Calibration Solutions fell 6% on supply chain shortages.
Unusual items: $356K in Agena integration costs; management cites FX, labor, and material headwinds.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.